• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
52,797.06 -686.99
(-1.28%)
Dow Jones
7,662.83 -66.15
(-0.86%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.63 -0.07
(-0.07%)
EUR-INR
111.19 0.41
(0.37%)
GBP-INR
129.81 0.28
(0.22%)
JPY-INR
0.60 0.00
(0.43%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
659.0470742
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
15.21
100732.9
EPS(TTM)
Face Value()
Div & Yield %
144.82
2
0.82
 

tulive developers ltd
CCL Products (India) consolidated net profit rises 12.43% in the March 2026 quarter
May 08,2026
Net profit of CCL Products (India) rose 12.43% to Rs 114.53 crore in the quarter ended March 2026 as against Rs 101.87 crore during the previous quarter ended March 2025. Sales rose 46.49% to Rs 1224.44 crore in the quarter ended March 2026 as against Rs 835.85 crore during the previous quarter ended March 2025.

For the full year,net profit rose 25.06% to Rs 388.10 crore in the year ended March 2026 as against Rs 310.34 crore during the previous year ended March 2025. Sales rose 43.52% to Rs 4457.37 crore in the year ended March 2026 as against Rs 3105.75 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1224.44835.85 46 4457.373105.75 44
OPM %15.6719.53 -16.4417.87 -
PBDT163.57132.84 23 612.62450.71 36
PBT123.14105.88 16 460.70352.25 31
NP114.53101.87 12 388.10310.34 25